Endologix, Inc. (NASDAQ:ELGX)

CAPS Rating: 2 out of 5

The Company develops, manufactures, sells and markets minimally invasive therapies for the treatment of cardiovascular disease.

Recs

1
Player Avatar dustbusterz (< 20) Submitted: 11/9/2007 7:04:34 PM : Underperform Start Price: $3.16 ELGX Score: -148.80

they may have a great produst or service to offer, but i fail to see any profitability thus far.

Featured Broker Partners


Advertisement